Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis

Affiliations

• ¹ Adult Cystic Fibrosis and CFTR-related disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland; Lung Transplant Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: Georgia.mitropoulou@chuv.ch.
• ² Adult Cystic Fibrosis and CFTR-related disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland; Lung Transplant Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.
• ³ Division of Pulmonology, Geneva University Hospitals, Switzerland.
• ⁴ Community Pharmacy, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.
• ⁵ Adult Cystic Fibrosis and CFTR-related disorders Center, Division of Pulmonology, Dept of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland; Division of Pulmonology, Neuchâtel Hospital Network, Neuchâtel, Switzerland.